With the first half of 2026 behind us, we recently reflected on the past three months of the year and all the valuable guidance we’ve seen published by North American and international societies across all medical specialties. Now, with six months still to go in 2026, we are taking a look ahead to guidelines that we anticipate will be published by the end of the year. 

In today's rundown, we are focusing specifically on anticipated guidelines focusing on cardiology topics. Links to current versions of the anticipated updates are included where available. Please note that all of the following guideline release windows are our best estimates and the actual release dates may change.

Most Anticipated Cardiology Guidance for Q3, Q4 2026
  • Primary Prevention Cardiovascular Disease
    • American College of Cardiology (ACC) /American Heart Association (AHA)
    • Q4 2026
    • Current Version
  • Resistant Hypertension Monitoring and Management
    • American College of Cardiology (ACC)
    • Q3 2026
  • Lipid Lowering Strategies in the Era of Early Atherosclerosis Detection
    • American College of Cardiology (ACC)
    • Q3 2026
  • Management of Heart Failure with Preserved Ejection Fraction
  • The Role of Nonstatin Lipid Lowering Therapies in ASCVD Risk Management

Be sure to check out our most recently posted cardiology-related content and sign up for alerts to stay informed on the latest published guidelines and articles.